MAPキナーゼキナーゼ、マイトジェン活性化プロテインキナーゼキナーゼ
- 関
- MAP kinase kinase、MAPK kinase、MAPK-ERK kinase、MAPKK、MEK
WordNet
- aerate (sewage) so as to favor the growth of organisms that decompose organic matter (同)aerate
- make (substances) radioactive
- make active or more active; "activate an old file"
- make more adsorptive; "activate a metal"
- rendered active; e.g. rendered radioactive or luminescent or photosensitive or conductive
- (of e.g. a molecule) made reactive or more reactive (同)excited
- (military) set up and placed on active assignment; "a newly activated unit"
- (of sewage) treated with aeration and bacteria to aid decomposition
- any of a large group of nitrogenous organic compounds that are essential constituents of living cells; consist of polymers of amino acids; essential in the diet of animals for growth and for repair of tissues; can be obtained from meat and eggs and milk and legumes; "a diet high in protein"
- an enzyme that catalyzes the conversion of a proenzyme to an active enzyme
- an agent that triggers mitosis
PrepTutorEJDIC
- …'を'活動的にする / …‘に'放射能を与える / 〈物質〉'を'活性化する
- 蛋白(たんばく)質
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2018/04/22 01:19:38」(JST)
[Wiki en表示]
"MKK" redirects here. For other uses, see MKK (disambiguation).
Mitogen-activated protein kinase kinase |
Identifiers |
EC number |
2.7.12.2 |
Databases |
IntEnz |
IntEnz view |
BRENDA |
BRENDA entry |
ExPASy |
NiceZyme view |
KEGG |
KEGG entry |
MetaCyc |
metabolic pathway |
PRIAM |
profile |
PDB structures |
RCSB PDB PDBe PDBsum |
Search |
PMC |
articles |
PubMed |
articles |
NCBI |
proteins |
|
Mitogen-activated protein kinase kinase (also known as MAP2K, MEK, MAPKK) is a kinase enzyme which phosphorylates mitogen-activated protein kinase (MAPK).
MAP2K is classified as EC 2.7.12.2.
There are seven genes:
- MAP2K1 (a.k.a. MEK1)
- MAP2K2 (a.k.a. MEK2)
- MAP2K3 (a.k.a. MKK3)
- MAP2K4 (a.k.a. MKK4)
- MAP2K5 (a.k.a. MKK5)
- MAP2K6 (a.k.a. MKK6)
- MAP2K7 (a.k.a. MKK7)
The activators of p38 (MKK3 and MKK6), JNK (MKK4 and MKK7), and ERK (MEK1 and MEK2) define independent MAP kinase signal transduction pathways.[1] The acronym MEK derives from MAPK/ERK Kinase.[2]
Contents
- 1 Role in melanoma
- 2 See also
- 3 References
- 4 External links
Role in melanoma
MEK is a member of the MAPK signaling cascade that is activated in melanoma.[3] When MEK is inhibited, cell proliferation is blocked and apoptosis(controlled cell death) is induced.
See also
- Signal transduction
- MAP kinase
- MAP kinase kinase kinase
- MAP kinase kinase kinase kinase
References
- ^ Dérijard B, et al. (1995). "Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms". Science. 267 (5198): 682–5. doi:10.1126/science.7839144. PMID 7839144.
- ^ Dwivedi, Gaurav; Kemp, Melissa L. (February 15, 2012). "Systemic Redox Regulation of Cellular Information Processing". Antioxidants & Redox Signaling. 16: 374–80. doi:10.1089/ars.2011.4034. PMC 3279717 . PMID 21939387.
- ^ Falchook, Gerald S.; Lewis, Karl D.; Infante, Jeffrey R.; Gordon, Michael S.; Vogelzang, Nicholas J.; DeMarini, Douglas J.; Fecher, Leslie A.; et al. (2012). "Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial". The Lancet Oncology. 13 (8): 782–789. doi:10.1016/S1470-2045(12)70269-3. PMC 4109286 . PMID 22805292.
External links
- Mitogen-Activated Protein Kinase Kinases at the US National Library of Medicine Medical Subject Headings (MeSH)
MAP kinase activation
|
Initiation |
|
MAP kinase kinase kinase (MAP3K or MKKK) |
- MAP kinase kinase kinases
- MAP3K1
- MAP3K2
- MAP3K3
- MAP3K4
- MAP3K5
- MAP3K6
- MAP3K7
- MAP3K8
- RAFs
- RAF1
- ARAF
- BRAF
- KSR1
- KSR2)
- MLKs
- MAP3K12
- MAP3K13
- MAP3K9
- MAP3K10
- MAP3K11
- MAP3K7
- ZAK
- CDC7
|
MAP kinase kinase (MAP2K or MKK) |
- MAP2K1
- MAP2K2
- MAP2K3
- MAP2K4
- MAP2K5
- MAP2K6
- MAP2K7
|
MAP kinase |
- Extracellular signal-regulated kinases
- C-Jun N-terminal kinases
- P38 mitogen-activated protein kinases
- MAPK11
- MAPK12
- MAPK13
- MAPK14
- ERK5 kinase
- Atypical MAPKs
|
Phosphatase |
|
Transferases: phosphorus-containing groups (EC 2.7)
|
2.7.1-2.7.4:
phosphotransferase/kinase
(PO4) |
2.7.1: OH acceptor |
- Hexo-
- Gluco-
- Fructo-
- Galacto-
- Phosphofructo-
- 1
- Liver
- Muscle
- Platelet
- 2
- Riboflavin
- Shikimate
- Thymidine
- NAD+
- Glycerol
- Pantothenate
- Mevalonate
- Pyruvate
- Deoxycytidine
- PFP
- Diacylglycerol
- Phosphoinositide 3
- Class I PI 3
- Class II PI 3
- Sphingosine
- Glucose-1,6-bisphosphate synthase
|
2.7.2: COOH acceptor |
- Phosphoglycerate
- Aspartate kinase
|
2.7.3: N acceptor |
|
2.7.4: PO4 acceptor |
- Phosphomevalonate
- Adenylate
- Nucleoside-diphosphate
- Uridylate
- Guanylate
- Thiamine-diphosphate
|
|
2.7.6: diphosphotransferase
(P2O7) |
- Ribose-phosphate diphosphokinase
- Thiamine diphosphokinase
|
2.7.7: nucleotidyltransferase
(PO4-nucleoside) |
Polymerase |
DNA polymerase |
- DNA-directed DNA polymerase
- I
- II
- III
- IV
- V
- RNA-directed DNA polymerase
- Reverse transcriptase
- Telomerase
- DNA nucleotidylexotransferase/Terminal deoxynucleotidyl transferase
|
RNA nucleotidyltransferase |
- RNA polymerase/DNA-directed RNA polymerase
- RNA polymerase I
- II
- III
- IV
- V
- Primase
- RNA-dependent RNA polymerase
- PNPase
|
|
Phosphorolytic
3' to 5' exoribonuclease |
|
Nucleotidyltransferase |
- UTP—glucose-1-phosphate uridylyltransferase
- Galactose-1-phosphate uridylyltransferase
|
Guanylyltransferase |
|
Other |
- Recombinase (Integrase)
- Transposase
|
|
2.7.8: miscellaneous |
Phosphatidyltransferases |
- CDP-diacylglycerol—glycerol-3-phosphate 3-phosphatidyltransferase
- CDP-diacylglycerol—serine O-phosphatidyltransferase
- CDP-diacylglycerol—inositol 3-phosphatidyltransferase
- CDP-diacylglycerol—choline O-phosphatidyltransferase
|
Glycosyl-1-phosphotransferase |
- N-acetylglucosamine-1-phosphate transferase
|
|
2.7.10-2.7.13: protein kinase
(PO4; protein acceptor) |
2.7.10: protein-tyrosine |
|
2.7.11: protein-serine/threonine |
- see serine/threonine-specific protein kinases
|
2.7.12: protein-dual-specificity |
- see serine/threonine-specific protein kinases
|
2.7.13: protein-histidine |
- Protein-histidine pros-kinase
- Protein-histidine tele-kinase
- Histidine kinase
|
|
Kinases: Serine/threonine-specific protein kinases (EC 2.7.11-12)
|
Serine/threonine-specific protein kinases (EC 2.7.11.1-EC 2.7.11.20)
|
|
|
Serine/threonine-specific protein kinases (EC 2.7.11.21-EC 2.7.11.30)
|
Polo kinase (EC 2.7.11.21) |
|
Cyclin-dependent kinase (EC 2.7.11.22) |
- CDK1
- CDK2
- CDKL2
- CDK3
- CDK4
- CDK5
- CDKL5
- CDK6
- CDK7
- CDK8
- CDK9
- CDK10
- CDK12
- CDC2L5
- PCTK1
- PCTK2
- PCTK3
- PFTK1
- CDC2L1
|
(RNA-polymerase)-subunit kinase (EC 2.7.11.23) |
- RPS6KA5
- RPS6KA4
- P70S6 kinase
- P70-S6 Kinase 1
- RPS6KB2
- RPS6KA2
- RPS6KA3
- RPS6KA1
- RPS6KC1
|
Mitogen-activated protein kinase (EC 2.7.11.24) |
- Extracellular signal-regulated
- MAPK1
- MAPK3
- MAPK4
- MAPK6
- MAPK7
- MAPK12
- MAPK15
- C-Jun N-terminal
- P38 mitogen-activated protein
|
MAP3K (EC 2.7.11.25) |
- MAP kinase kinase kinases
- MAP3K1
- MAP3K2
- MAP3K3
- MAP3K4
- MAP3K5
- MAP3K6
- MAP3K7
- MAP3K8
- RAFs
- MLKs
- MAP3K12
- MAP3K13
- MAP3K9
- MAP3K10
- MAP3K11
- MAP3K7
- ZAK
- CDC7
- MAP3K14
|
Tau-protein kinase (EC 2.7.11.26) |
|
(acetyl-CoA carboxylase) kinase (EC 2.7.11.27) |
|
Tropomyosin kinase (EC 2.7.11.28) |
|
Low-density-lipoprotein receptor kinase (EC 2.7.11.29) |
|
Receptor protein serine/threonine kinase (EC 2.7.11.30) |
- Bone morphogenetic protein receptors
- BMPR1
- BMPR1A
- BMPR1B
- BMPR2
- ACVR1
- ACVR1B
- ACVR1C
- ACVR2A
- ACVR2B
- ACVRL1
- Anti-Müllerian hormone receptor
|
|
|
Dual-specificity kinases (EC 2.7.12)
|
MAP2K |
- MAP2K1
- MAP2K2
- MAP2K3
- MAP2K4
- MAP2K5
- MAP2K6
- MAP2K7
|
|
|
Enzymes
|
Activity |
- Active site
- Binding site
- Catalytic triad
- Oxyanion hole
- Enzyme promiscuity
- Catalytically perfect enzyme
- Coenzyme
- Cofactor
- Enzyme catalysis
|
Regulation |
- Allosteric regulation
- Cooperativity
- Enzyme inhibitor
|
Classification |
- EC number
- Enzyme superfamily
- Enzyme family
- List of enzymes
|
Kinetics |
- Enzyme kinetics
- Eadie–Hofstee diagram
- Hanes–Woolf plot
- Lineweaver–Burk plot
- Michaelis–Menten kinetics
|
Types |
- EC1 Oxidoreductases (list)
- EC2 Transferases (list)
- EC3 Hydrolases (list)
- EC4 Lyases (list)
- EC5 Isomerases (list)
- EC6 Ligases (list)
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Antioxidant and anti-ageing activities of citrus-based juice mixture.
- Kim DB1, Shin GH1, Kim JM1, Kim YH1, Lee JH1, Lee JS1, Song HJ2, Choe SY3, Park IJ4, Cho JH5, Lee OH6.
- Food chemistry.Food Chem.2016 Mar 1;194:920-7. doi: 10.1016/j.foodchem.2015.08.094. Epub 2015 Aug 24.
- The production of excessive reactive oxygen species by exposure to oxidative stress and solar radiation are primary factors in skin damage. We examined the effects of a citrus-based juice mixture and its bioactive compounds on antioxidant and anti-ageing activities in human dermal fibroblasts and ha
- PMID 26471635
- Leptin Effect on Acetylation and Phosphorylation of Pgc1α in Muscle Cells Associated With Ampk and Akt Activation in High-Glucose Medium.
- García-Carrizo F1, Nozhenko Y1, Palou A1, Rodríguez AM1.
- Journal of cellular physiology.J Cell Physiol.2016 Mar;231(3):641-9. doi: 10.1002/jcp.25109.
- Leptin is crucial in energy metabolism, including muscle regulation. Peroxisome proliferator activated receptor gamma co-activator 1α (PGC1α) orchestrates energy metabolism and is tightly controlled by post-translational covalent modifications such as phosphorylation and acetylation. We aimed to f
- PMID 26218179
- Raf kinase inhibitor protein mediated signaling inhibits invasion and metastasis of hepatocellular carcinoma.
- Wu X1, Yang Y2, Xu Z1, Li J1, Yang B1, Feng N1, Zhang Y1, Wang S3.
- Biochimica et biophysica acta.Biochim Biophys Acta.2016 Feb;1860(2):384-91. doi: 10.1016/j.bbagen.2015.06.009. Epub 2015 Jun 25.
- BACKGROUND: Hepatocellular carcinoma (HCC) is the most common type of liver cancer with high mortality and poor prognosis. Mitogen-activated protein kinase (MAPK) and nuclear factor kappa B (NF-κB) signaling pathways have been implicated in promoting tumor cell proliferation and invasion of HCC cel
- PMID 26116914
Japanese Journal
- Doxycycline Hyclate Protects Lipopolysaccharide-Induced Endothelial Barrier Dysfunction by Inhibiting the Activation of p38 Mitogen-Activated Protein Kinase
- Xia Jian-ling,Wang Li-qun,Wu Li-li [他]
- Biological & pharmaceutical bulletin 37(12), 1882-1890, 2014-12
- NAID 40020277754
- Inhibition of Mitogen-Activated Protein Kinases Phosphorylation Plays an Important Role in the Anti-nociceptive Effect of Pregabalin in Zymosan-Induced Inflammatory Pain Model
- Jeong Young Chan,Pyun Kihyun,Kwon Young Bae
- Biological & pharmaceutical bulletin 37(10), 1694-1698, 2014-10
- NAID 40020224838
- Hydroxysafflor Yellow A Attenuates Small Airway Remodeling in a Rat Model of Chronic Obstructive Pulmonary Disease
- Wang Yu,Xue Changjiang,Dong Fang [他]
- Biological & pharmaceutical bulletin 37(10), 1591-1598, 2014-10
- NAID 40020224588
Related Links
- Wikipedia(ウィキペディア)記事検索 > [ Mitogen-activated protein kinase ] の検索結果
- This gene encodes a member of the mitogen-activated protein kinase (MAPK) family. Members of this family act as an integration point for multiple biochemical signals and are involved in a wide variety of cellular ...
Related Pictures
★リンクテーブル★
[★]
MAPキナーゼキナーゼ
- 関
- MAP kinase kinase、MAPK-ERK kinase、MAPKK、MEK、mitogen-activated protein kinase kinase
[★]
- 英
- mitogen-activated protein kinase kinase、MAP kinase kinase、MEK
- 関
- MAPキナーゼキナーゼ、MAPK-ERKキナーゼ
[★]
MAPK-ERKキナーゼ
- 関
- MAP kinase kinase、MAPK kinase、MAPKK、MEK、mitogen-activated protein kinase kinase
[★]
マイトジェン活性化プロテインキナーゼキナーゼ4
- 関
- JNK kinase、MAP kinase kinase 4
[★]
マイトジェン活性化プロテインキナーゼキナーゼ3
- 関
- MAP kinase kinase 3
[★]
マイトジェン活性化プロテインキナーゼキナーゼ5
- 関
- MAP kinase kinase 5
[★]
マイトジェン活性化プロテインキナーゼキナーゼ6
- 関
- MAP kinase kinase 6
[★]
- 関
- activate、activated form、activation、turn on
[★]
- 関
- activated、activation、turn on
[★]
キナーゼ カイネース リン酸化酵素 phosphoenzyme phosphotransferase
[★]
プロテインキナーゼ
- 同
- protein kinases